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Introduction
In the last decades a remarkable empirical phenomenon has occurred in the drug markets. The retail prices of well-known hard drugs have declined spectacularly. We show the evidence in figures 1 and 2. These present the price evolution (at the retail level) of cocaine and heroin in the US and in Europe. We observe that these prices have dropped from 50% to 80% since 1990.
There is evidence that these retail price declines started before 1990, and that it also applies to other drugs than cocaine and heroin 1 . We show some evidence for the US where these data have been collected for a longer time (since 1981) . In this paper we will concentrate on the period since 1990 because that period has the most consistent set of data.
How can such a spectacular price decline be explained? This is the question addressed in this paper. We start by presenting a very simple model of demand and supply of drugs, so as to identify the potential factors that can explain this price decline. We then formulate our hypothesis, which is that the forces of globalization are the main reason why drug prices have declined. Globalization has fundamentally affected the drug industry in different ways. We will analyze these different mechanisms. In a further section we present some empirical evidence that confirm our main hypothesis.
We conclude with a section on the policy implications of our findings.
. 1 For cannabis, most widely used drug we could not find long enough time series of prices. 
Demand and supply of drugs
In this section we present a simple model of demand and supply in the drugs market 2 .
The purpose of this classroom model is to identify the factors that can be invoked to explain the large decline in the retail price of drugs. We will call the drug in this very simple model "cocaine".
Figure 3 presents demand and supply for cocaine at the retail level. We focus first on the supply curve. This embodies an important characteristic of the drug market i.e.
that by far the largest part of the retail cost consists of the intermediation margin. The cost of producing coca leafs is a tiny fraction of the total retail cost. It is variously estimated to be less than 1% of the retail price (see Caulkins, et al.(2005) ).
Thus the intermediation margin constitutes by far the largest part of the retail price. The relation between the retail and producer (farmer) supply curves represented in figure 1 can be analyzed as follows. We start by writing the producer supply curve as a simple linear function with unit price elasticity 3 :
where P f is the producer price and X S is the supply of cocaine. We then write the retail price as follows:
Where P is the retail price and M is the intermediation margin. We specify the latter as:
where M is the fixed component of the intermediation margin and What are the factors affecting the intermediation margin? Let us list the most important ones.
• The risk premium. Since the distribution and sale of drugs is illegal in most countries and since the penalty on these activities is stiff, those who engage in these activities take a risk (confiscation, prison, violence.). They will only engage in these activities if they obtain a risk premium 4 . Given the nature of the risk, this risk premium is likely to be large. This factor is likely to make the fixed component of the intermediation margin large.
• Efficiency of intermediation. The more efficient the intermediation process (stock management, transportation and distribution) the lower the costs. There is a potential spillover here with the risk premium: a more efficient intermediation reduces the number of intermediaries involved and thus reduces the risk premium.
Substituting (2) and (3) into (1) yields:
which describes the retail supply curve. Note that the slope of the retail supply curve (given by α + β) will generally be different from the slope of the producer supply curve (given by α).
This simple model allows us to write the elasticity of the retail supply curve as
Equation (5) implies that if the fixed intermediation margin is high, the retail price elasticity can become very large. Equation (5) can be rewritten as
One can simplify (6) further by assuming that β = 0, i.e. the intermediation margin has only a fixed component 5 . In that case we obtain the following expression for the price elasticity of the retail supply:
i. e. the price elasticity of the retail supply curve is equal to the ratio of the retail price to the producer price (given that we have assumed a unit price elasticity of the producer supply curve) 6 . The larger is this ratio, the higher is the price elasticity of the retail supply curve for any given elasticity of the producer supply curve. To illustrate the nature of equation (5), suppose that the retail price is 100 times higher than the producer price (which is the order of magnitude observed in reality 7 ), then the price elasticity of the retail supply curve will be equal to 100 (given that the producer supply equation has unit elasticity). Thus in the drug market the price elasticity of the retail supply is likely to be several orders of magnitude higher than the price elasticity of the producers' supply. 5 This assumption makes sense as we really do not know how the supply affects the risk premium, i.e.
we do not know whether β is positive or negative. 6 As mentioned earlier this assumption is made for the sake of simplicity. Making a more general assumption will not alter the main result, i.e. that the price elasticity of the retail supply is a multiple of the price elasticity of the producers' supply. The previous theoretical analysis allows us to identify the likely causes of the large observed decline in retail prices. Such a decline can be due to three different causes
• An increased supply by producers Second, the massive price declines are unlikely to have been the result of declines in demand. These would have had to be massive also. This follows from the fact that the retail supply curve is relatively elastic. The latter follows from the existence of a large intermediation margin. Thus, in order to produce a retail price decline of 80%, a demand reduction should have been truly massive. We will analyze whether there is any empirical evidence for such a large decline of demand.
Given that shifts in the supply and demand curves are unlikely candidates to explain the large observed price declines, the core of the explanation is likely to be found in large reductions in the intermediation margin. In other words, the large price declines are likely to be due to a combination of large declines in the risk premium and large increases in the efficiency of the intermediation.
In the next section we provide some empirical evidence on the evolution of the three factors identified in this section.
Empirical analysis
The way we precede in this section is as follows. We present statistical information on the three fundamental determinants of the retail price of drugs, i.e, on the worldwide production and consumption of drugs and on the intermediation margin.
Worldwide supply of drugs.
We supply data on the three most important drugs, cocaine, heroin and cannabis. The worldwide production of opium (used to produce heroin) is shown in figure 5.
The production of opium is concentrated in mainly three countries, Afghanistan, Myanmar and Laos. We observe a similar trend as in the cocaine market, i.e. a stagnating worldwide production. As in the case of cocaine, this trend conceals two opposing tendencies. On the one hand, there is a significant decline in the worldwide area under cultivation from more that 250,000 ha in 1990 to about 150,000 in 2005.
On the other hand, the international efforts at eradicating the cultivation of poppy has been countered by an increase in the yield per ha. In this section we also show some evidence on other drugs than cocaine and heroin, in particular on cannabis. In contrast to cocaine and opium the production of cannabis is not regionally concentrated. Cannabis, either in the form of herb or resin, can be produced in virtually every country. According to the UN World Drug Report (2006) cannabis herb is cultivated in some 176 countries (p. 103). This makes the estimation of the worldwide production very difficult. Nevertheless some rough indication of the trends in the worldwide supply can be obtained. Figure 6 shows an estimate of the evolution of the worldwide production of cannabis herb since the end of the 1980s.
We observe that after a decline in the worldwide production in the 1990s, production has picked up again since the late 1990s. As a result in 2004/05 the production stood approximately 36% above the level of the late 1980s. Thus, in contrast to the cocaine and heroin markets, we observe an increase in the worldwide production of cannabis.
This increase, however, remains relatively limited, amounting to less than 2% per year.
To conclude this discussion of the trends in production it is useful to analyze the price evolution at the producer level ("farm-gate prices"). The data that can be found are not as comprehensive as the production data (i.e., we could not find reliable producer prices of cannabis over an extended period). Also, the price data typically cover only part of the different producing countries. 
Worldwide consumption of drugs
In the following three figures 9-11 we present the evolution of the use of heroin, cocaine and cannabis in Europe and in the US. The general picture we obtain is that the drug use in Europe and the US has been on an upward trend since the early 1990s.
In Europe the use of heroin and cocaine has increased faster than their worldwide use, while in the US the use of these same drugs has increased less fast than in the rest of the world. As far as cannabis is concerned, both the European and the US consumption levels have increased faster than world consumption.
Thus the picture we obtain from this analysis of consumption data and from the previous section's analysis of the production side is the following. The increased demand for drugs (at the retail level) has put upward pressure on the producer prices.
Production, however, has not increased much (in the cases of coca and opium)
probably because of the efforts of eradication have reduced the cultivation areas.
However, higher yields per ha have made it possible for producers to continue to supply approximately the same amount of drugs in the world markets.
From this analysis it appears that the sharp decline in the retail prices cannot easily be explained by the trends in world production and consumption. Indeed, the paradox we noted in the beginning is even stronger than we thought. Retail prices have declined dramatically despite an increase in the producer prices during the same period. This leads us into an analysis of the intermediation margin. 
The collapse of the intermediation margins
The spectacular decline in the retail prices of cocaine and heroin can only be explained by what happened with the intermediation margins in these markets. We
show the evidence about these intermediation margins in figures 12 and 13. We first concentrate on the margin between the retail and the wholesale price. The latter is not the producer price but the price paid by the dealers in the consuming markets. We will analyze the margin between the wholesale price and the producer price subsequently. Figure 12 shows the intermediation margin between the retail and wholesale prices for cocaine and heroin. The decline of these margins is spectacular amounting to 50% or more from 1990 to 2004.
We obtain a similar result with the intermediation margins between the wholesale and the producer prices. We show the evidence in figure 13 . When computing these margins we assumed that the producer prices remained constant at their 2004 levels.
We do this because we only have fragmentary information of these producer prices (see previous section). We know that these prices tended to increase though. Thus we tend to underestimate the decline of the margin. We observe from figure 13 that the margin between the wholesale and producer price declined even more than the margin between retail and wholesale price, dropping by 60 to 80%. From the previous evidence it can be concluded that the spectacular decline in the retail prices of cocaine and heroin can be explained almost exclusively by the spectacular declines in the intermediation margins between producers, wholesalers and retailers. Thus the story that can be told about the observed decline in retail prices is the following. For some reason (to be analyzed in the next section) the intermediation margins in the cocaine and heroin markets dropped spectacularly since at least 1990. This had the effect of reducing retail prices substantially. The latter then stimulated the demand for drugs by end-users. This increased demand in turn had the effect of pushing up producer prices for coca leafs and opium. As the producer prices make up only a tiny fraction of the retail value of drugs (even after the decline in the retail prices) the second round effect of the increased producer prices in the retail markets were extremely small. We now come to the question of why the intermediation margins declined so much, which leads us to the analysis of the effects of globalization on the drug market.
Globalization and the intermediation margins in the drug markets
Our hypothesis is that globalization has worked in two ways to reduce the intermediation margins in the drug business. The first one is the efficiency effect of It is not easy to find direct evidence for this hypothesis. There is, however, some indirect evidence available that tends to support the risk premium effect. This is the number of drug seizures observed since 1990. We show the evidence in figure 14. We observe that there is a dramatic increase in the worldwide seizures of heroin and cocaine. Since 1980 the number of worldwide seizures has increased by a factor of 10.
(A similar phenomenon is observed with other drugs). Such an increase in seizures can be interpreted in two ways. First, it can be used as evidence that the effectiveness of law enforcement has increased. Second, it can be the result of increased trafficking.
If the first hypothesis is the correct one, we should observe an increase in the intermediation margin. The reason is that more forceful law enforcement increases the risk of distributing drugs. The strongly declining margins observed in the previous section, however, cast doubts on this interpretation. We may then conclude that the large increases in drug seizures have also been influenced by increased trafficking.
This lends support to our hypothesis that globalization has led to an increased supply of individuals willing to enter the drug distribution business. It also follows that the large increases in drug seizures have been insufficient to curb the surge in trafficking. 
Globalization and inflation
The effect of globalization on the retail prices of drugs is not an isolated phenomenon.
There 
Policy implications
We showed that the forces of globalization have led to large declines in the retail prices of drugs (cocaine and heroin). This together with the evidence about the price elasticity of the demand for drugs suggests that globalization has contributed towards increasing drug use. Thus globalization has conflicted with the stated objectives of governments in the world. Almost everywhere these governments aim at reducing drug use.
These governments have followed different approaches towards achieving the objective of a lower drug use. A first approach consists in containing supply by law enforcement measures (control and interdiction of production and distribution). A second approach consists in undertaking measures that reduce demand for drugs (prevention, information and education).
Most governments use a combination of these two types of policies. Some put more emphasis on supply policies while others focus more on demand policies 11 . The results of our paper allow us to draw a tentative conclusion on the relative effectiveness of these two approaches in the context of a globalized environment. This is that globalization has tended to make demand policies relatively more effective than supply policies. We show this in the context of the model of demand and supply of drugs in figure 15 . We assume that globalization continues to induce a decline in the intermediation margin. Graphically, the retail supply curve continues to shift downwards. As a result, demand is stimulated further. These forces of globalization tend to undermine the effectiveness of supply containment policies. The reason can be seen as follows. Supply containment policies tend to raise the margin between retail and producer prices. In the absence of globalization this would raise the retail supply curve upwards. Globalization, however, greatly reduces this upward movement, and on balance continues to push it downwards. The main reason follows from a paradox contained in supply policies: as the latter raise the intermediation margin, they increase the profitability of the drug business and thus they tend to attract many new agents seeking to capture the enlarged profit opportunities (see Becker et al(2004) ) 12 .
The reduced effectiveness of supply policies in a world of globalization creates the scope for an enhanced use of demand policies. Even if the latter are not more effective than before, their relative effectiveness may have increased. We show the effects of demand policies in figure 15 by a downward movement of the demand curve. We also note that the high elasticity of the retail supply curve has the effect of making this 11 There are other differences between governments in the use they make of harm reduction. Some governments give harm reduction a central place in their overall drug policies; other governments give it only scant importance. The role of harm reduction in drug policies is outside the scope of this paper. 12 Becker et al. (2004) show that if the demand of illicit drugs is relatively inelastic, interdiction and law enforcement will actually increase the resources devoted to the supply of drugs.
shift in the demand curve relatively effective in reducing demand because it has only a very small impact on the price of drugs 13 . These policies can be used to counteract the effects of globalization on the supply curve.
This conclusion, it should be stressed, can only be tentative. More research effort should go toward analyzing the conditions in which demand policies can be made to work. In addition, our conclusion does not imply that supply containment policies should be abandoned. These are likely to remain an important part of any drug policy aiming at reducing drug use. 
Conclusion
The retail prices of major drugs like cocaine and heroin have declined dramatically during the last two decades. This price decline has tended to offset the effects of drug policies aimed at reducing drug use in major industrial countries.
The main finding of this paper is that the decline in the retail prices of drugs is related to the strong decline in the intermediation margin (the difference between the retail and producer prices) in the drug business. This margin has tended to decline by more than 50% since 1990 in the US and in Europe.
We developed the hypothesis, and gave some evidence, that globalization has been an important factor behind the decline of the intermediation margin. Globalization has achieved this effect in two ways. We called the first one the efficiency effect of globalization. Lower transport costs, the use of the new IT and the enhanced worldwide competition have allowed to dramatically improve the efficiency of the distribution of drugs. In addition, the greater efficiency of the distribution process had the effect of making it easier to conceal the transport and the stock management of drugs.
The second mechanism through which globalization has lowered the intermediation margin is through the risk premium effect. Globalization has opened the borders of many countries with a surplus of poor and low skilled workers. Millions of "havenots" who have little to loose, may have been attracted by the fantastic intermediation margins provided by the drug market. This massive entry into the business of transporting and distributing drugs by people who are willing to take risks helps to explain the decline in the risk premium.
We concluded with some thoughts about the effects of globalization on the effectiveness of drug policies and argued that globalization may have increased the relative effectiveness of policies aiming at reducing the demand of drugs.
Source: http://www.whitehousedrugpolicy.gov/publications/price_purity/
